Literature DB >> 19424098

B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia.

Daniel Kondziella1, Mattias Göthlin, Michael Fu, Henrik Zetterberg, Anders Wallin.   

Abstract

High levels of B-type natriuretic peptide (BNP), a serum marker of congestive heart failure, are associated with an increased risk for cognitive decline. However, no study has yet assessed this marker in different subtypes of dementia. We tested the hypothesis that BNP has a more significant association with vascular dementia than Alzheimer disease. Plasma BNP was measured in 15 patients with subcortical vascular dementia, in 19 Alzheimer patients without evidence of vascular comorbidity, and in age-matched controls. Compared with controls (28+/-7 ng/l), BNP was elevated in subcortical vascular dementia (63+/-17 ng/l; P=0.03), but not in Alzheimer disease (36+/-5 ng/l). In conclusion, subcortical vascular dementia is indeed associated with moderately elevated BNP levels, whereas this could not be shown for Alzheimer disease. This probably reflects the larger cardiovascular burden in patients with subcortical vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424098     DOI: 10.1097/WNR.0b013e328326f82f

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.

Authors:  Matej Mihelčić; Goran Šimić; Mirjana Babić Leko; Nada Lavrač; Sašo Džeroski; Tomislav Šmuc
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

2.  Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults.

Authors:  Lori B Daniels; Gail A Laughlin; Donna Kritz-Silverstein; Paul Clopton; Wei-Chung Chen; Alan S Maisel; Elizabeth Barrett-Connor
Journal:  Am J Med       Date:  2011-07       Impact factor: 4.965

3.  Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

Authors:  Holly D Soares; William Z Potter; Eve Pickering; Max Kuhn; Frederick W Immermann; David M Shera; Mats Ferm; Robert A Dean; Adam J Simon; Frank Swenson; Judith A Siuciak; June Kaplow; Madhav Thambisetty; Panayiotis Zagouras; Walter J Koroshetz; Hong I Wan; John Q Trojanowski; Leslie M Shaw
Journal:  Arch Neurol       Date:  2012-10

Review 4.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

Review 5.  Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.

Authors:  Yongyao Fu; Deming Zhao; Lifeng Yang
Journal:  J Mol Neurosci       Date:  2014-06-25       Impact factor: 3.444

6.  Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

Authors:  William T Hu; David M Holtzman; Anne M Fagan; Leslie M Shaw; Richard Perrin; Steven E Arnold; Murray Grossman; Chengjie Xiong; Rebecca Craig-Schapiro; Christopher M Clark; Eve Pickering; Max Kuhn; Yu Chen; Vivianna M Van Deerlin; Leo McCluskey; Lauren Elman; Jason Karlawish; Alice Chen-Plotkin; Howard I Hurtig; Andrew Siderowf; Frank Swenson; Virginia M-Y Lee; John C Morris; John Q Trojanowski; Holly Soares
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

7.  Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Authors:  Josef Marksteiner; Douglas Imarhiagbe; Michaela Defrancesco; Eberhard A Deisenhammer; Georg Kemmler; Christian Humpel
Journal:  Exp Gerontol       Date:  2013-12-10       Impact factor: 4.032

8.  Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.

Authors:  Insa Feinkohl; Naveed Sattar; Paul Welsh; Rebecca M Reynolds; Ian J Deary; Mark W J Strachan; Jackie F Price
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

9.  Markers of cardiac dysfunction in cognitive impairment and dementia.

Authors:  Saima Hilal; Yuek Ling Chai; Mohammad Kamran Ikram; Sakktivel Elangovan; Tan Boon Yeow; Xu Xin; Jun Yi Chong; Narayanaswamy Venketasubramanian; Arthur Mark Richards; Jenny P C Chong; Mitchell Kim Peng Lai; Christopher Chen
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 10.  Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.

Authors:  A Wallin; E Kapaki; M Boban; S Engelborghs; D M Hermann; B Huisa; M Jonsson; M G Kramberger; L Lossi; B Malojcic; S Mehrabian; A Merighi; E B Mukaetova-Ladinska; G P Paraskevas; B O Popescu; R Ravid; L Traykov; G Tsivgoulis; G Weinstein; A Korczyn; M Bjerke; G Rosenberg
Journal:  BMC Neurol       Date:  2017-05-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.